XML 20 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net loss $ (1,599,375) $ (1,199,315)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of warrant liability (199)
Change in fair value of derivative liability (29,291) (160,789)
Loss on excess fair value of derivative liability 890,640 36,317
Gain on settlement of accounts payable and accrued liabilities (16,785)
Excess fair value if shares issued in connection with convertible note 3,200
Excess fair market value of shares issued 30,815
Gain on sale of land (66,220)
Share-based compensation 144
Amortization 26,381 53,977
Depreciation 275
Excess fair value of common stock issued for accrued interest 7,200
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (2,917) 8,314
Accounts payable 98,432 269,353
Accrued liabilities 404,870 831,775
Net cash used in operating activities (177,245) (235,953)
Cash flows from investing activities:    
Proceeds from sale of land 175,328
Net cash used in investing activities 175,328
Cash flows from financing activities:    
Proceeds from related party line of credit/notes payable 15,321 195,694
Net cash provided by financing activities 15,321 195,694
Net increase in cash and cash equivalents (161,924) 135,069
Cash and cash equivalents beginning of year 161,991 26,922
Cash and cash equivalents end of year 67 161,991
Supplemental disclosures of cash flow information    
Interest 13,216
Income taxes 2,939
Supplemental schedule of non-cash investing and financing activities:    
Conversion of non-secured convertible notes payable 25,000 52,950
Interest converted to common stock 12,547
Derivative liability reclassified to additional paid-in capital 30,354 139,303
Note payable issued for services 49,982 25,000
Discount on convertible notes payable
Gain on settlement of shares $ 10,335